Search

Por primera vez, un fármaco dirigido está mostrando resultados prometedores en el tratamiento del cáncer pulmonar de células no pequeñas causado por una mutación llamada KRAS-G12D.

… Sunday, April 27, 2025 Durante décadas, los casos de cáncer con mutaciones en el gen  KRAS  se consideraron “no tratables con fármacos”. Las mutaciones en KRAS  se encuentran presentes en más del 20 % de los casos de cáncer. Son más comunes en el  cáncer pulmonar ,  el cáncer de páncreas y el  cáncer

The collective efforts of the “TeamLabs” will accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers

… Tuesday, April 19, 2022 Today, one year after its founding, Break Through Cancer has awarded Memorial Sloan Kettering Cancer Center (MSK) more than $12 million in grants to intercept cancer at the earliest stages and find cures to several of the deadliest cancers. This funding is part of a total of $50

Two important clinical trials to increase treatment options for mantle cell lymphoma patients are currently recruiting patients.

… Friday, August 14, 2020 In a biologically-related B-cell Non-Hodgkin lymphoma/leukemia called chronic lymphocytic leukemia (CLL), it is well-established that novel biologically-targeted therapies are more effective than standard chemotherapy in patients with TP53 mutation or deletion. Based on this previous

Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.

… Tuesday, September 12, 2023 An experimental prostate cancer treatment uses MRI to target radiation and intensify the dose to the tumor — and at the same time reduce side effects.     It’s more precise because MSK radiation oncologists take multiple MRI images during the procedure to adjust for tumor

With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured.

… Wednesday, May 26, 2021 VIDEO | 00:25 A Developing Mouse Embryo This movie from the Kat Hadjantonakis lab shows an 11-day-old mouse embryo with its internal organs labeled in different fluorescence. The video was prepared by postdoc Evan Bardot. Video Details If you’ve ever explored Google Earth, you

Learn how to organize your medical records once and for all.

… Friday, January 31, 2025 Summary Making the decision to sort that pile of papers on your desk is an accomplishment in and of itself. Two experts who know the ins and outs of medical records share their best tips for cataloging it all. Organizing can be onerous, but the payoffs are powerful. Less clutter

In patients with progressive, refractory, or symptomatic desmoid tumors, sorafenib (Nexavar®) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective in slowing disease progression.

… Wednesday, December 19, 2018 Bottom Line: In patients with progressive, refractory, or symptomatic desmoid tumors , sorafenib (Nexavar ® ) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective

Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation.

… Thursday, January 14, 2021 Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation, according to our research published online first in Ophthalmology Retina . Worldwide, removing the affected eye has been the standard

可通过眼动脉化学外科 (OAC) 方式对视网膜母细胞瘤伴脉络膜侵犯的患者进行成功治疗，避免眼球摘除。

… Thursday, January 14, 2021 我们首次在线发表在 《眼科视网膜》(Ophthalmology Retina) 上的研究表明，对视网膜母细胞瘤伴脉络膜侵犯的患者，可以通过眼动脉化学外科 (OAC) 方式进行成功治疗，避免眼球摘除。 在世界范围内，摘除受累一侧的眼球一直是管理脉络膜浸润的标准方式。 近期，有很多临床医生开始质疑视网膜母细胞瘤伴脉络膜浸润是否真正有较高的转移率，患者是否有必要进行眼球摘除和多药辅助全身化疗的高强度治疗。  (1) 我们对包含 4 例双侧视网膜母细胞瘤儿童患者的小型病例系列进行了一项回顾性综述，这些患者均伴随有大量直径大于 3 毫米的脉络膜浸润病灶

A new imaging approach involving lasers and sound waves produces high-resolution pictures of tumor blood vessels.

… Wednesday, March 18, 2020 Summary Cancer drugs targeting the blood vessels that nourish tumors have shown mixed results. A new laser-based, high-resolution imaging technique could be a noninvasive tool for showing how these blood vessels change in response to therapy. Cancer needs a steady supply of